Victor Sandor's Insider Trades & SAST Disclosures
Victor Sandor's most recent trade in Kymera Therapeutics Inc was a trade of 16,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Victor Sandor.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics Inc | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Adc Therapeutics SA | Victor Sandor | Director | Sale of securities on an exchange or to another person at price $ 2.89 per share. | 17 Jun 2024 | 6,995 | 80,886 | - | 2.9 | 20,216 | Common Shares |
| Prelude Therapeutics Inc | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | |
| Adc Therapeutics SA | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 40,000 | 87,881 | - | 0 | Common Shares | |
| Merus N.V | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 8,844 | 8,844 | - | - | Share Option (right to buy) | |
| Prelude Therapeutics Inc | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 23,500 | 23,500 | - | - | Director Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Merus N.V | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 14,414 | 14,414 | - | - | Share option (right to buy) | |
| Kymera Therapeutics Inc | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 34,300 | 34,300 | - | - | Director Stock Option (Right to Buy) | |
| Merus N.V | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 16,604 | 16,604 | - | - | Share option (right to buy) | |
| Prelude Therapeutics Inc | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 11,206 | 11,206 | - | - | Director Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 8,022 | 8,022 | - | - | Director Stock Option (Right to Buy) | |
| Prelude Therapeutics Inc | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2021 | 23,344 | 23,344 | - | - | Director Stock Option (Right to Buy) | |
| Merus N.V | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 6,120 | 6,120 | - | - | Share option (right to buy) | |
| Prelude Therapeutics Inc | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2020 | 3,458 | 3,458 | - | - | Director Stock Option (right to buy) | |
| Merus N.V | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 8,631 | 8,631 | - | - | Share Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges